NETTER-1 Phase III in Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-Dotatate: Efficacy and Safety Results

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING(2016)

Cited 32|Views17
No score
Abstract
NETTER-1 Phase III in Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE : Efficacy and Safety Results
More
Translated text
Key words
Lutathera,PRRT,NET
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined